I am a medical oncologist and my 25-year career as an oncologist has been focused on creating cutting-edge treatments for patients with lung cancer. This is a disease with unacceptable outcomes, but there are many promising therapies today and on the horizon. I was named to the Castle Connolly list of “America's Top Doctors” from 2004-2018 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016.
My research has been in the molecular biology of lung tumors, which includes understanding the genetic, proteomic and metabolic features of each patient’s cancer, and developing treatment and drugs that target specific tumor cells.
I’ve served as an investigator on multiple clinical trials, including the large phase III lung cancer trials, for the Eastern Cooperative Oncology Group (ECOG), one of the largest clinical cancer research organizations in the U.S. Additionally, I’ve authored more than 200 peer-reviewed publications, book chapters and articles. I have served on several National Cancer Institute (NCI) grant review panels and the NCI Board of Scientific Counselors.
In 2012, I came to Ohio State from Vanderbilt University to establish and direct the OSUCCC – James thoracic center. With our multidisciplinary team approach, we apply advanced molecular diagnostics and state-of-the-art therapeutics to provide personalized care every lung cancer patient. I also serve as a professor of internal medicine and hold the Barbara J. Bonner Chair in Lung Research. I currently serve as the President of the International Association for the Study of Lung Cancer (IASLC).
The collaborative spirit, team approach, dedicated patient care and enlightened leadership we enjoy at the OSUCCC – James all come together together to make this a great place to work – and a great place to receive treatment for cancer.